Magosch, Petra
Lichtenberg, Sven
Tauber, Mark
Martetschläger, Frank
Habermeyer, Peter
Article History
Received: 4 October 2019
First Online: 23 April 2020
Compliance with ethical standards
:
: Petra Magosch and their immediate family, and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. Sven Lichtenberg is a consultant of Arthrex Inc. and receives royalties. Mark Tauber is a consultant of Arthrex Inc. Frank Martetschläger is a consultant of Arthrex Inc. Peter Habermeyer receives patent royalties for the Universal Glenoid™ implant from Arthrex Inc.
: This study was approved by the Institutional Review Board of the ATOS Clinics Heidelberg and Munich (Study No. 4/18).